Engineered immune cells aim to keep HIV in check
NCT ID NCT06252402
First seen Feb 24, 2026 · Last updated May 01, 2026 · Updated 8 times
Summary
This study tests a new treatment for people living with HIV. It uses specially designed immune cells (CMV-HIV CAR T cells) to target and control the virus. The goal is to see if this approach is safe and possible, while participants continue their regular HIV medications. About 15 adults with well-controlled HIV will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact
-
UCSD, Division of Infectious Diseases and Global Public Health
RECRUITINGSan Diego, California, 92093, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.